GFS Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Hold |
|
|||||
|
2025
Q1 | $1.3M | Sell |
|
|||||
|
2024
Q4 | $1.59M | Sell |
|
|||||
|
2024
Q3 | $1.87M | Buy |
|
|||||
|
2024
Q2 | $1.78M | Sell |
|
|||||
|
2024
Q1 | $1.73M | Buy |
|
|||||
|
2023
Q4 | $1.11M | Sell |
|
|||||
|
2023
Q3 | $928K | Sell |
|
|||||
|
2023
Q2 | $1.06M | Buy |
|
|||||
|
2023
Q1 | $976K | Sell |
|
|||||
|
2022
Q4 | $1.07M | Buy |
|
|||||
|
2022
Q3 | $1.02M | Sell |
|
|||||
|
2022
Q2 | $966K | Sell |
|
|||||
|
2022
Q1 | $1.33M | Buy |
|
|||||
|
2021
Q4 | $1.39M | Buy |
|
|||||
|
2021
Q3 | $1.49M | Buy |
|
|||||
|
2021
Q2 | $1.36M | Buy |
|
|||||
|
2021
Q1 | $1.13M | Buy |
|
|||||
|
2020
Q4 | $968K | Buy |
|
|||||
|
2020
Q3 | $674K | Buy |
|